cholecystokinin 9 has been researched along with vasoactive intestinal peptide in 1 studies
Studies (cholecystokinin 9) | Trials (cholecystokinin 9) | Recent Studies (post-2010) (cholecystokinin 9) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
---|---|---|---|---|---|
23 | 1 | 3 | 10,873 | 123 | 1,221 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christophe, J; De Neef, P; Pradayrol, L; Robberecht, P; Scemama, JL; Vaysse, N; Waelbroeck, M | 1 |
1 other study(ies) available for cholecystokinin 9 and vasoactive intestinal peptide
Article | Year |
---|---|
CCK and gastrin inhibit adenylate cyclase activity through a pertussis toxin-sensitive mechanism in the tumoral rat pancreatic acinar cell line AR 4-2J.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclase Inhibitors; Animals; Cell Membrane; Cholecystokinin; Gastrins; Guanosine Triphosphate; Pancreas; Pancreatic Neoplasms; Pentagastrin; Peptide Fragments; Pertussis Toxin; Rats; Secretin; Tetragastrin; Tumor Cells, Cultured; Vasoactive Intestinal Peptide; Virulence Factors, Bordetella | 1988 |